Putting the BRK on breast cancer: From molecular target to therapeutics

BReast tumor Kinase (BRK, also known as PTK6) is a non-receptor tyrosine kinase that is highly expressed in breast carcinomas while having low expression in the normal mammary gland, which hints at the oncogenic nature of this kinase in breast cancer. In the past twenty-six years since the discovery...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Theranostics
Main Authors: Ang, Hui Li, Yuan, Yi, Lai, Xianning, Tan, Tuan Zea, Wang, Lingzhi, Huang, Benjamin BoJun, Pandey, Vijay, Huang, Ruby Yun-Ju, Lobie, Peter E., Goh, Boon Cher, Sethi, Gautam, Yap, Celestial T., Chan, Ching Wan, Lee, Soo Chin, Kumar, Alan Prem
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738883/
https://ncbi.nlm.nih.gov/pubmed/33391524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.49716
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki